September 24, 2025 |
Inizio has appointed Mary-Kate McGarry as Chief Strategy & Innovation Officer and Gavin McShera as Chief Information Officer, strengthening its executive leadership to drive innovation, digital transformation, and Intelligent Commercialization™ across the health and life sciences sector.

We are proud to announce the strategic appointment of two senior executives to our leadership team – advancing innovation, operational excellence, and digital transformation across the organization.Â
Joining the Executive Team are Mary-Kate McGarry as Chief Strategy & Innovation Officer and Gavin McShera as Chief Information Officer. These appointments strengthen our ability to deliver Intelligent Commercialization™ – seamlessly connecting science, technology, and human expertise to unlock value across every stage of the health and life sciences journey.Â
Mary-Kate, who served as Vice President, Global & Corporate Strategy since 2022, now joins the Executive Team as Chief Strategy & Innovation Officer. In this role, she will lead corporate strategy, innovation, global marketing, and brand development.Â
Since joining Inizio in 2021, following the merger of UDG Healthcare and Huntsworth, Mary-Kate has played a pivotal role in shaping the integrated corporate strategy and aligning strategic priorities across the business. As Chief Strategy & Innovation Officer, she will accelerate our Intelligent Commercialization™ approach – harnessing innovation, strategy realization, and AI-driven transformation, with a focus on:Â
Prior to joining Inizio, Mary-Kate built a tenured career in management consulting, working with executive teams across healthcare, financial services, and government sectors to lead large-scale transformation and growth programs.Â
Gavin McShera, who has served as Inizio’s CIO since 2021, now joins our Executive Team. With three decades of global experience in technology leadership across healthcare, retail, finance, aviation, and the public sector, Gavin continues to oversee our enterprise technology strategy, while playing a broader role in shaping organizational leadership.Â
As CIO, Gavin oversees our enterprise technology strategy, focusing on:Â
Before joining UDG Healthcare in 2021, Gavin served as Group CIO at Applegreen PLC and held roles at Microsoft and as an independent consultant.Â
With these appointments, we reinforce our commitment to being a market-leading, trusted commercialization partner for health and life sciences companies worldwide. At Inizio, we bring together data, technology, and multidisciplinary expertise to simplify complexity, reduce risk, and deliver consistent value across the commercialization journey.Â
Learn more about our leadership team. Â
This content was provided by Inizio
Latest Content from Inizio
Pegasus shortlisted for three Communiqué awards and hopes to defend its Communications Consultancy of the Year win from 2014
An overview of the PsO biologic and systemic patientOur PsO market snapshot offers an introduction to the real world patient data collected by our Therapy Watch PsO study. The snapshot...
An overview of the prostate cancer patientDownload our Therapy Watch PCa market snapshot which provides you with an overview of the prostate cancer patient and the therapy regimens followed by...
Latin AmericaThe LATAM regions largest markets of Argentina, Brazil, Chile, Colombia, Mexico and Venezuela, is home to more than 460 million people and is a key global growth region. With...
An overview of the RA biologic patientOur RA market snapshot will provide you with an introduction to the treatment pathways followed by RA patients treated with biologic agents. Our analyses...
The Central and Eastern Europe region is home to over 145 million people and is a key global growth region. With pharmaceutical sales set to exceed $27bn in 2014, it...
Home to over half a billion people, the ASEAN region constitutes the eighth largest economy in the world. With pharmaceutical sales projected to exceed $20 billion in 2014, it’s an...
Referencing data from our Living with HCV survey undertaken with patients in the US and China, this infographic explores the roadblocks encountered on the path to effective and compliant treatment.Hepatitis C is...
Published in eye for pharma 3 April by Marc Yates
Published in Medical Marketing & Media March 2015
